checkAd
    Startseite > Aktien > Genmab > Nachrichten
    Genmab
    Aktie
    ISIN: DK0010272202 WKN: 565131 SYM: GE9 Land Dänemark
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    244,90
     
    EUR
    -0,33 %
    -0,80 EUR
    Letzter Kurs 14.06.24 Tradegate
    Geldkurs
    14.06.24
    243,90
     
    EUR
    13 STK
    Briefkurs
    14.06.24
    245,80
     
    EUR
    13 STK

    Genmab Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Grant of Restricted Stock Units and Warrants to Employees in Genmab
    12.06.24 · globenewswire · Genmab
    Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
    11.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    10.06.24 · globenewswire · Genmab
    Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
    05.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    03.06.24 · globenewswire · Genmab
    Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    03.06.24 · globenewswire · Genmab
    Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
    02.06.24 · globenewswire · Genmab
    Investigational Acasunlimab (DuoBody -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
    01.06.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    27.05.24 · globenewswire · Genmab
    Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
    23.05.24 · globenewswire · Genmab
    Genmab Completes Acquisition of ProfoundBio
    21.05.24 · globenewswire · Genmab
    Transactions in Connection with Share Buy-back Program
    21.05.24 · globenewswire · Genmab